Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Hepatocellular

Explore clinical trials studying Carcinoma, Hepatocellular. Study availability and eligibility vary by location and protocol.

2,099 public trials 529 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Hepatocellular trial results

Active, Not Recruiting

Study of Cabozantinib in Combination With Atezolizumab Versus Sorafenib in Participants With Advanced Hepatocellular Carcinoma (HCC) Who Have Not Received Previous Systemic Anticancer Therapy

NCT03755791

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations
  • Exelixis Clinical Site #208 Phoenix, Arizona, United States
  • Exelixis Clinical Site #159 Tucson, Arizona, United States
  • Exelixis Clinical Site #44 La Jolla, California, United States
  • Exelixis Clinical Site #112 Los Angeles, California, United States
View all 245 locations
View Trial Details
Active, Not Recruiting

BOXR1030 T Cells in Subjects With Advanced GPC3-Positive Solid Tumors

NCT05120271

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +28 more
Locations
  • Hoag Hospital Newport Beach Newport Beach, California, United States
  • Baylor Scott and White Research Institute Dallas, Texas, United States
  • University of Texas MD Anderson Cancer Center Houston, Texas, United States
  • Fred Hutchinson Cancer Center - Seattle Cancer Care Alliance (SCCA) Location Seattle, Washington, United States
View Trial Details
Active, Not Recruiting

A Study of Imaging, Blood, and Tissue Samples to Guide Treatment of Colon Cancer and Related Liver Tumors

NCT03432806

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +17 more
Locations
  • Memorial Sloan Kettering Basking Ridge Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Commack Commack, New York, United States
  • Memorial Sloan Kettering Westchester Harrison, New York, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
View Trial Details
Active, Not Recruiting

Naptumomab Estafenatox in Combination With Durvalumab in Subjects With Selected Advanced or Metastatic Solid Tumor, Including a Cohort Expansion in Esophageal Cancer.

NCT03983954

Conditions
Adenocarcinoma, Adenocarcinoma Of Esophagus, Adenoma, +79 more
Locations
  • Shalby Hospital Ahmedabad, Gujarat, India
  • National Cancer Institute Jhajjar, Haryana, India
  • All India Institute of Medical Sciences New Delhi, India
  • PMCH (Pacific Medical College & Hospital) Udaipur, Rajasthan, India
View Trial Details
Active, Not Recruiting

A Study of Nivolumab in Participants With Hepatocellular Carcinoma Who Are at High Risk of Recurrence After Curative Hepatic Resection or Ablation

NCT03383458

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +10 more
Locations
  • Local Institution - 0081 Anniston, Alabama, United States
  • Mayo Clinic in Arizona - Phoenix Phoenix, Arizona, United States
  • Arizona Oncology Associates, PC - HOPE Tucson, Arizona, United States
  • Local Institution - 0135 Los Angeles, California, United States
View all 184 locations
View Trial Details
Active, Not Recruiting

The HistoSonics System for Treatment of Primary and Metastatic Liver Tumors Using Histotripsy

NCT04572633

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +10 more
Locations
  • Miami Cancer Institute Miami, Florida, United States
  • Tampa General Hospital Tampa, Florida, United States
  • University of Chicago Chicago, Illinois, United States
  • University of Kansas Medical Center Kansas City, Kansas, United States
View Trial Details

Related conditions